T3 Pharmaceuticals
SwitzerlandEntry
2019
Hold
4yr
Exit
2023
Who owns T3 Pharmaceuticals?
T3 Pharmaceuticals is a Swiss Biotech company, now owned by Boehringer Ingelheim, which acquired it in 2023 from Boehringer Ingelheim Venture Fund.
Hand-verified · updated 2026-07-07
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Boehringer Ingelheim
Exit Year
2023
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
Germany
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns T3 Pharmaceuticals?
T3 Pharmaceuticals is now owned by Boehringer Ingelheim, which acquired it in 2023 from Boehringer Ingelheim Venture Fund.
When did Boehringer Ingelheim acquire T3 Pharmaceuticals?
Boehringer Ingelheim acquired T3 Pharmaceuticals in 2023, buying from Boehringer Ingelheim Venture Fund.
Who did T3 Pharmaceuticals sell to?
Boehringer Ingelheim Venture Fund sold T3 Pharmaceuticals to Boehringer Ingelheim in 2023 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue